Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Jul 30 - Jul 30, 2024

Tumor

42,144
3
0
29,184
51
06.00AM - 07.00AM
Metastatic Disease of the Extremity
MOD: UAMS
2 1 1
Session Files
06.00AM - 06.30AM
QB Questions for Metastatic Disease of the Extremity
07.00AM - 08.00AM
Malignant Chondrogenic Bone Tumors
MOD: ,
1 5
Session Files
PMID: 28666625: Is intralesional resection suitable for central grade 1 chondrosarcoma: A systematic review and updated meta-analysis.
PMID: 16260673: Surgical treatment and outcome of conventional pelvic chondrosarcoma.
PMID: 20889950: Secondary chondrosarcoma.
PMID: 24668351: Pelvic resection: current concepts.
PMID: 25382793: Intralesional curettage and cementation for low-grade chondrosarcoma of long bones: retrospective study and literature review.
QB Questions for Malignant Chondrogenic Bone Tumors
08.00AM - 09.00AM
Malignant Osteogenic Bone Tumors
MOD: ,
4 6 5
Session Files
C101985: Distal Femur Osteosarcoma in 13F
C102335: Proximal Humerus Tumor in 21M
C101542: Left Femur Tumor in a 13M
C101053: Knee Pain with Blastic Lesion in 30F
C1166: Tibial osteosarcoma in a 12-year-old boy
PMID: 24942962: What are the 5-year survivorship outcomes of compressive endoprosthetic osseointegration fixation of the femur?
PMID: 25274928: Does a pathological fracture affect the prognosis in patients with osteosarcoma of the extremities? : a systematic review and meta-analysis.
PMID: 26665241: Osteosarcoma: A Meta-Analysis and Review of the Literature.
PMID: 18949052: Resection of parosteal osteosarcoma of the distal part of the femur: an original reconstruction technique with cement and plate.
PMID: 19652033: Osteosarcoma.
PMID: 31191985: Current review of surgical management options for extremity bone sarcomas.
QB Questions for Malignant Osteogenic Bone Tumors
Event POLLS
This is a private stream. Please join the product to view this stream.